Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?

Ann Rheum Dis. 2021 Jul;80(7):e120. doi: 10.1136/annrheumdis-2019-215819. Epub 2019 Jun 12.

Authors

Emanuel Raschi¹, Ippazio Cosimo Antonazzo², Elisabetta Poluzzi², Fabrizio De Ponti²

Affiliations

¹ Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy emanuel.raschi@unibo.it.
² Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

PMID: 31189551
DOI: 10.1136/annrheumdis-2019-215819

No abstract available

Keywords: epidemiology; systemic lupus erythematosus; treatment.

Publication types

Letter
Comment

MeSH terms

Humans
Immune Checkpoint Inhibitors
Lupus Erythematosus, Systemic* / chemically induced
Lupus Erythematosus, Systemic* / drug therapy
Pharmaceutical Preparations*

Substances

Immune Checkpoint Inhibitors
Pharmaceutical Preparations